New treatment option for Hypertension
Official title County Medical Community-based, Cardiovascular Risk Stratified Integrated Care Model: a Pragmatic Cluster Randomised Control Trial
ClinicalTrials.gov ID: NCT06302127
What this study is testing
- What it's testing
- The goal of this cluster randomized trial is to evaluate the effectiveness of the RISIMA model based on an integrated county healthcare consortium implemented by multi-level family health teams (FHTs)on patients with diabetes and/or hypertension, including CVD risk assessment, treatment, and management.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 70
You may be able to join if
- Aged between 40 and 70 years old;
- Patients with hypertension or diabetes;
- Permanent residents of the county where the research is conducted;
- Already signed up with the family doctor team in the township where the research is located.
You likely can't join if
- Unable to independently carry out the interventions required for the study;
- Residing far from the village or township health center where the research is located, making it difficult to cooperate with visits;
- Patients who refuse to participate;
- Patients with comorbidities such as cancer that may interfere with the study visits or intervention effects;
- Pregnant or lactating women
The study team makes the final eligibility decision.
Where it's taking place
- Sanming, Fujian, China
- Liuzhou, Guangxi, China
- Liuzhou, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sanming, Fujian, China; Liuzhou, Guangxi, China; Liuzhou, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.